{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:30:12Z","timestamp":1791250212372,"version":"4.1.0"},"reference-count":43,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pan Afr Med J"],"abstract":"<jats:p>Introduction: limited studies describe the epidemiology, clinical presentation, and outcome of mpox in Rivers State, Nigeria.\n\n \n\nMethods: an observational retrospective study of suspected mpox cases seen between October 21, 2021, and April 30, 2023, at the University of Port Harcourt Teaching Hospital, Rivers State, Nigeria. Laboratory confirmation was by qPCR testing of skin swabs, or crust samples. A data extraction form was used to obtain sociodemographic and clinical data. The primary outcome was the rate of hospitalization and death. Data was analyzed using IBM SPSS version 25. A p-value of &lt;0.05 was considered statistically significant.\n\n \n\nResults: of 35 participants, 24 (68.6%) were males with a mean age [standard deviation] of 33.7 (\u00b1 9.9 years), and 5 (14.3%) had HIV infection. The majority (n=33, 94.3%) reported being in a heterosexual relationship with a household identified as the probable place of contact (n=13, 72.2%). None of the patients reported contact with animals or a travel history. The most common symptoms were skin rash (35, 100%), followed by fever (26, 74.3%), and fatigue (26, 74.3%). Concomitant varicella zoster virus infection (n=6, 17.1%), hospital admission (n=28, 80%), and death (n=3, 8.6%) were observed. There was a statistically significant association between mortality and patients with HIV (p = 0.002).\n\n \n\nConclusion: the 2022-23 mpox outbreak in Rivers State predominantly affected young adults and was characterized by human-to-human transmission and typical febrile rash syndrome with an association between mpox mortality and HIV infection. Targeted public health interventions are needed to control the spread of mpox in Nigeria.<\/jats:p>","DOI":"10.11604\/pamj.supp.2025.50.1.46067","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:18:32Z","timestamp":1766067512000},"source":"Crossref","is-referenced-by-count":6,"title":["Epidemiology, clinical presentation and outcome of human Mpox in Rivers State, Nigeria during the 2022-23 outbreak: an observational retrospective study"],"prefix":"10.11604","author":[{"given":"Chizaram","family":"Onyeaghala","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiye","family":"Somiari","sequence":"additional","affiliation":[{"name":"Department of Community of Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujile","family":"Ichechiek","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ogan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope","family":"Avundaa","sequence":"additional","affiliation":[{"name":"Department of Community of Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odianosen","family":"Ehiakhamen","sequence":"additional","affiliation":[{"name":"Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8021-4265","authenticated-orcid":false,"given":"Bolaji Ibiesa","family":"Otike-Odibi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omosivie","family":"Maduka","sequence":"additional","affiliation":[{"name":"Department of Community of Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Datonye","family":"Alasia","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4870","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"ref0","unstructured":"World Health Organization. Mpox. Accessed Nov 24, 2024."},{"key":"ref1","unstructured":"Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y et al. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis. 2019;19(8):872-9. PubMed | Google Scholar"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses. 2020;12(11):1257. PubMed | Google Scholar","DOI":"10.3390\/v12111257"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Pembi E, Omoleke S, Paul H, Augustine T, Cuevas LE. Monkeypox outbreak in a correctional center in North Eastern Nigeria. J Infect. 2022 Dec 1;85(6):702-69. PubMed | Google Scholar","DOI":"10.1016\/j.jinf.2022.09.010"},{"key":"ref4","unstructured":"World Health Organization African Region. African region faces an unprecedented surge in mpox cases. August 8, 2024. Accessed Nov 24, 2024."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Chika-Igwenyi NM, Unigwe US, Ajayi NA, Onwe OE, Ewa RL, Ojide CK et al. Atypical mpox in a Nigerian Tertiary Health Facility. J Infect Dis. 2024 Mar 26;229(Supplement_2):S181-S187. PubMed | Google Scholar","DOI":"10.1093\/infdis\/jiad607"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Happi C, Adetifa I, Mbala P, Njouom R, Nakoune E, Happi A et al. Urgent need for a non-discriminatory and non-stigmatizing nomenclature for the monkeypox virus. PLoS Biol. 2022 Aug 23;20(8):e3001769. PubMed | Google Scholar","DOI":"10.1371\/journal.pbio.3001769"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis. 2019 Oct;13(10):e0007791. PubMed | Google Scholar","DOI":"10.1371\/journal.pntd.0007791"},{"key":"ref8","unstructured":"World Health Organization. 2022-24 mpox (Monkeypox) Outbreak: Global Trends. 2024. Accessed on Nov 22, 2024."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141. PubMed | Google Scholar","DOI":"10.1371\/journal.pntd.0010141"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Okoli GN, Van Caeseele P, Askin N, Abou-Setta AM. Comparative evaluation of the clinical presentation and epidemiology of the 2022 and previous mpox outbreaks: a rapid review and meta-analysis. Infect Dis (Lond). 2023 Jul;55(7):490-508. PubMed | Google Scholar","DOI":"10.1080\/23744235.2023.2214609"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Thornhill JP, Antinori A, Orkin CM. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. N Engl J Med. 2022 Aug 25;387(8):679-691. PubMed | Google Scholar","DOI":"10.1056\/NEJMc2213969"},{"key":"ref12","unstructured":"World Health Organization African Region. African CDC and WHO launch joint continental plan to scale up mpox outbreak response. 2024. Accessed Nov 19, 2024."},{"key":"ref13","unstructured":"Henderson DA. Smallpox and its eradication. WHO; 1988."},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Gomez-Garberi M, Sarrio-Sanz P, Martinez-Cayuelas L, Delgado-Sanchez E, Bernabeu-Cabezas S, Peris-Garcia J et al. Genitourinary Lesions Due to Monkeypox. Eur Urol. 2022 Dec;82(6):625-30. PubMed | Google Scholar","DOI":"10.1016\/j.eururo.2022.08.034"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Tar\u00edn-Vicente EJ, Alemany A, Agud-Dios M, Ubals M, Su\u00f1er C, Ant\u00f3n A et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet. 2022 Aug 27;400(10353):661-9. PubMed | Google Scholar","DOI":"10.1016\/S0140-6736(22)01436-2"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Miura F, van Ewijk CE, Backer JA, Xiridou M, Franz E, Op de Coul E et al. Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022. Euro Surveill. 2022 Jun;27(24):2200448. PubMed | Google Scholar","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200448"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Mmerem JI, Umenzekwe CC, Johnson SM, Onukak AE, Chika-Igwenyi NM, Chukwu SK et al. Mpox and Chickenpox Coinfection: Case Series From Southern Nigeria. J Infect Dis. 2024 Mar 26;229(Supplement_2):S260-S264. PubMed| Google Scholar","DOI":"10.1093\/infdis\/jiad556"},{"key":"ref18","unstructured":"Mitj\u00e0 O, Alemany A, Marks M, Mora JIL, Rodr\u00edguez-Aldama JC, Silva MST et al. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023 Mar 18;401(10380):939-49. PubMed| Google Scholar"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Ogoina D, Dalhat MM, Denue BA, Okowa M, Chika-Igwenyi NM, Oiwoh SO et al. Mpox Epidemiology and Risk Factors, Nigeria, 2022. Emerg Infect Dis. 2024 Sep;30(9):1799-808. PubMed | Google Scholar","DOI":"10.3201\/eid3009.240135"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ogoina D, Dalhat MM, Denue BA, Okowa M, Chika-Igwenyi NM, Yusuff HA et al. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study. Lancet Infect Dis. 2023 Dec;23(12):1418-1428. PubMed | Google Scholar","DOI":"10.1016\/S1473-3099(23)00427-9"},{"key":"ref21","unstructured":"Parker E, Omah IF, Varilly P, Magee A, Ayinla AO, Sijuwola AE et al. Genomic epidemiology uncovers the timing and origin of the emergence of mpox in humans. medRxiv [Preprint]. 2024 Jun 19:2024.06.18.24309104. PubMed | Google Scholar"},{"key":"ref22","unstructured":"Rivers (State, Nigeria). Population Statistics, Charts, Map and Location. Accessed on Nov 24 2024."},{"key":"ref23","unstructured":"Nigeria Centre for Disease Control. National monkeypox public health response guidelines. Accessed on November 24, 2024."},{"key":"ref24","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery, and monitoring: recommendations for a public health approach. Jul 2021. Accessed on Nov 22, 2024."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Ogoina D, Iroezindu M, James HI, Oladokun R, Yinka-Ogunleye A, Wakama P et al. Clinical Course and Outcome of Human Monkeypox in Nigeria. Clin Infect Dis. 2020 Nov 5;71(8):e210-4. PubMed | Google Scholar","DOI":"10.1093\/cid\/ciaa143"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Onu HC, Golden O, Wali IA, Adedire BE, Balogun M, Chidinma E et al. Epidemiology of human Monkey-pox cases in Rivers State, Nigeria January 2017-June 2022. Front Public Health. 2023 Jan 4:10:1039604. PubMed | Google Scholar","DOI":"10.3389\/fpubh.2022.1039604"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Vivancos R, Anderson C, Blomquist P, Balasegaram S, Bell A, Bishop L et al. Community transmission of monkeypox in the United Kingdom, April to May 2022. Eurosurveillance. 2022 Jun 2;27(22):2200422. PubMed | Google Scholar","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200422"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Ogoina D, James HI. Mpox among Linked Heterosexual Casual Partners in Bayelsa, Nigeria. New Engl J Med. 2023 May 31;388(22):2101-4. PubMed | Google Scholar","DOI":"10.1056\/NEJMc2300866"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Gao L, Shi Q, Dong X, Wang M, Liu Z, Li Z. Mpox, Caused by the MPXV of the Clade IIb Lineage, Goes Global. Trop Med Infect Dis. 2023 Feb;8(2):76. PubMed | Google Scholar","DOI":"10.3390\/tropicalmed8020076"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Kinganda-Lusamaki E, Amuri-Aziza A, Fernandez-Nu\u00f1ez N, Makangara-Cigolo JC, Pratt C, Vakaniaki EH et al. Clade I mpox virus genomic diversity in the Democratic Republic of the Congo, 2018-2024: Predominance of zoonotic transmission. Cell. 2025 Jan 9;188(1):4-14.e6. PubMed | Google Scholar","DOI":"10.1016\/j.cell.2024.10.017"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Rangaraj A, Connor S, Harding R, Pinto C, Chitembo L, Ford N. Advanced HIV disease and health-related suffering-exploring the unmet need of palliative care. Lancet HIV. 2023 Feb 1;10(2):e126-33. PubMed | Google Scholar","DOI":"10.1016\/S2352-3018(22)00295-8"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Hoff NA, Morier DS, Kisalu NK, Johnston SC, Doshi RH, Hensley LEet al. Varicella Coinfection in Patients with Active Monkeypox in the Democratic Republic of the Congo. Ecohealth. 2017 Sep;14(3):564-74. PubMed | Google Scholar","DOI":"10.1007\/s10393-017-1266-5"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Tumewu J, Wardiana M, Ervianty E, Sawitri, Rahmadewi, Astindari et al. An adult patient with suspected of monkeypox infection differential diagnosed to chickenpox. Infect Dis Rep. 2020 Jul 6;12(Suppl 1):8724. PubMed | Google Scholar","DOI":"10.4081\/idr.2020.8724"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Long B, Liang SY, Carius BM, Chavez S, Gottlieb M, Koyfman A et al. Mimics of Monkeypox: Considerations for the emergency medicine clinician. Am J Emerg Med. 2023 Mar;65:172-8. PubMed | Google Scholar","DOI":"10.1016\/j.ajem.2023.01.007"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Stephen R, Alele F, Olumoh J, Tyndall J, Okeke MI, Adegboye O. The epidemiological trend of monkeypox and monkeypox-varicella zoster virus co-infection in North-Eastern Nigeria. Front Pub Health. 2022 Dec 15;10:1066589. PubMed | Google Scholar","DOI":"10.3389\/fpubh.2022.1066589"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Rimoin AW, Kisalu N, Kebela-Ilunga B, Mukaba T, Wright LL, Formenty P et al. Endemic human monkeypox, Democratic Republic of Congo, 2001-2004. Emerg Infect Dis. 2007 Jun;13(6):934-7. PubMed | Google Scholar","DOI":"10.3201\/eid1306.061540"},{"key":"ref37","unstructured":"Onyeaghala C, Iroezindu M. Human Monkeypox Outbreak in Non-Endemic Countries. The Need for Global Health Action. J Niger Infect Dis Soc. 2022;1(2):1-3."},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Griffith DC, Fall A, Carter M, Traut CC, Sop J, Hansoti B et al. Mpox Recurrence and Tecovirimat Resistance in a Patient With Advanced Human Immunodeficiency Virus Disease. Open Forum Infect Dis. 2024 Sep 23;11(10):ofae549. PubMed | Google Scholar","DOI":"10.1093\/ofid\/ofae549"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Smith TG, Gigante CM, Wynn NT, Matheny A, Davidson W, Yang Y et al. Tecovirimat Resistance in mpox Patients, United States, 2022-2023. Emerg Infect Dis. 2023 Dec;29(12):2426-2432. PubMed | Google Scholar","DOI":"10.3201\/eid2912.231146"},{"key":"ref40","unstructured":"Synapse. PALM 007 Study Results for Tecovirimat in mpox Treatment Released. August 23, 2024."},{"key":"ref41","unstructured":"National Institutes of Health (NIH). 2024. The antiviral tecovirimat is safe but did not improve clade I mpox resolution in the Democratic Republic of the Congo. Accessed Nov 24, 2024."},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Warner NC, Shishido A, Fulco PP, Sastry S. Immune reconstitution inflammatory syndrome due to monkeypox in two patients with AIDS. AIDS. 2023 Jun 1;37(7):1187-1188. PubMed | Google Scholar","DOI":"10.1097\/QAD.0000000000003541"}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:18:41Z","timestamp":1766067521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/series\/50\/1\/5\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":43,"URL":"https:\/\/doi.org\/10.11604\/pamj.supp.2025.50.1.46067","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"article-number":"46067"}}